Budnick Hailey C, Tomlinson Samuel, Savage Jesse, Cohen-Gadol Aaron
Neurological Surgery, Indiana University, Indianapolis, USA.
Neurological Surgery, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, USA.
Cureus. 2020 May 17;12(5):e8171. doi: 10.7759/cureus.8171.
Cerebral vasospasm is a rare life-threatening complication of transsphenoidal surgery (TSS). We report our experience with two cases of symptomatic vasospasm after endoscopic TSS, alongside a systematic review of published cases. Two patients who underwent endoscopic TSS for resection of a tuberculum sella meningioma (case 1) and pituitary adenoma (case 2) developed symptomatic vasospasm. Clinical variables, including demographics, histopathology, the extent of subarachnoid hemorrhage (SAH), diabetes insipidus (DI), day of vasospasm, vasospasm symptoms, vessels involved, management, and clinical outcome, were retrospectively extracted. We subsequently reviewed published cases of symptomatic post-TSS vasospasm. Including our two cases, we identified 34 reported cases of TSS complicated by symptomatic vasospasm. Female patients accounted for 20 (58.8%) of 34 cases. The average age was 48.1 ± 12.9 years. The majority of patients exhibited postoperative SAH (70.6%). The average delay to vasospasm presentation was 8.5 ± 3.6 days. The majority of patients exhibited vasospasm in multiple vessels, typically involving the anterior circulation. Hemodynamic augmentation with hemodilution, hypertension, and hypervolemia was the most common treatment. Death occurred in six (17.6%) of 34 patients. Common deficits included residual extremity weakness (17.6%), pituitary insufficiency (8.8%), and cognitive deficits (8.8%). Symptomatic vasospasm is a rare, potentially fatal complication of TSS. The most consistent risk factor is SAH. Early diagnosis requires a high index of suspicion when confronted with intractable DI, acute mental status change, or focal deficits in the days after TSS. Morbidity and death are significant risks in patients with this complication.
脑血管痉挛是经蝶窦手术(TSS)罕见的危及生命的并发症。我们报告了两例内镜下TSS术后出现症状性血管痉挛的经验,并对已发表病例进行了系统回顾。两名因切除鞍结节脑膜瘤(病例1)和垂体腺瘤(病例2)而接受内镜下TSS的患者出现了症状性血管痉挛。回顾性提取了临床变量,包括人口统计学、组织病理学、蛛网膜下腔出血(SAH)程度、尿崩症(DI)、血管痉挛发生日期、血管痉挛症状、受累血管、治疗方法及临床结局。随后,我们回顾了已发表的TSS术后症状性血管痉挛病例。包括我们的两例在内,我们共识别出34例报告的TSS合并症状性血管痉挛病例。34例患者中女性占20例(58.8%)。平均年龄为48.1±12.9岁。大多数患者术后出现SAH(70.6%)。血管痉挛出现的平均延迟时间为8.5±3.6天。大多数患者多支血管出现血管痉挛,通常累及前循环。血液稀释、高血压和高血容量的血流动力学强化是最常见的治疗方法。34例患者中有6例(17.6%)死亡。常见的后遗症包括肢体残留无力(17.6%)、垂体功能不全(8.8%)和认知缺陷(8.8%)。症状性血管痉挛是TSS罕见的、潜在致命的并发症。最一致的危险因素是SAH。TSS术后数天内,当面对难治性DI、急性精神状态改变或局灶性缺陷时,早期诊断需要高度的怀疑指数。这种并发症患者的发病率和死亡率风险很高。